21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Genomic Epidemiology of Major Extraintestinal Pathogenic Escherichia coli Lineages Causing Urinary Tract Infections in Young Women Across Canada

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          A few extraintestinal pathogenic Escherichia coli (ExPEC) multilocus sequence types (STs) cause the majority of community-acquired urinary tract infections (UTIs). We examine the genomic epidemiology of major ExPEC lineages, specifically factors associated with intestinal acquisition.

          Methods

          A total of 385 women with UTI caused by E. coli across Canada were asked about their diet, travel, and other exposures. Genome sequencing was used to determine both ST and genomic similarity. Logistic regression was used to identify factors associated with the acquisition of and infection with major ExPEC STs relative to minor ExPEC STs.

          Results

          ST131, ST69, ST73, ST127, and ST95 were responsible for 54% of all UTIs. Seven UTI clusters were identified, but genomes from the ST95, ST127, and ST420 clusters exhibited as few as 3 single nucleotide variations across the entire genome, suggesting recent acquisition. Furthermore, we identified a cluster of UTIs caused by 6 genetically-related ST1193 isolates carrying mutations in gyrA and parC. The acquisition of and infection with ST69, ST95, ST127, and ST131 were all associated with increased travel. The consumption of high-risk foods such as raw meat or vegetables, undercooked eggs, and seafood was associated with acquisition of and infection with ST69, ST127, and ST131, respectively.

          Conclusions

          Reservoirs may aid in the dissemination of pandemic ExPEC lineages in the community. Identifying ExPEC reservoirs may help prevent future emergence and dissemination of high-risk lineages within the community setting.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: not found
          • Article: not found

          Aligning Sequence Reads, Clone Sequences and Assembly Contigs with BWA-MEM

          H. Li, Li, H Li (2013)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance

            Escherichia coli represents an incredible versatile and diverse enterobacterial species and can be subdivided into the following; (i) intestinal non-pathogenic, commensal isolates. (ii) Intestinal pathogenic isolates and (iii) extraintestinal pathogenic E. coli or ExPEC isolates. The presence to several putative virulence genes has been positively linked with the pathogenicity of ExPEC. E. coli remains one of the most frequent causes of nosocomial and community-acquired bacterial infections including urinary tract infections, enteric infections, and systemic infections in humans. ExPEC has emerged in 2000s as an important player in the resistance to antibiotics including the cephalosporins and fluoroquinolones. Most importantly among ExPEC is the increasing recognition of isolates producing “newer β-lactamases” that consists of plasmid-mediated AmpC β-lactamases (e.g., CMY), extended-spectrum β-lactamases (e.g., CTX-M), and carbapenemases (e.g., NDM). This review will highlight aspects of virulence associated with ExPEC, provide a brief overview of plasmid-mediated resistance to β-lactams including the characteristics of the successful international sequence types such as ST38, ST131, ST405, and ST648 among ExPEC.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem.

              Escherichia coli is probably the best-known bacterial species and one of the most frequently isolated organisms from clinical specimens. Despite this, underappreciation and misunderstandings exist among medical professionals and the lay public alike regarding E. coli as an extraintestinal pathogen. Underappreciated features include (i) the wide variety of extraintestinal infections E. coli can cause, (ii) the high incidence and associated morbidity, mortality, and costs of these diverse clinical syndromes, (iii) the pathogenic potential of different groups of E. coli strains for causing intestinal versus extraintestinal disease, and (iv) increasing antimicrobial resistance. In this era in which health news often sensationalizes uncommon infection syndromes or pathogens, the strains of E. coli that cause extraintestinal infection are an increasingly important endemic problem and underappreciated "killers". Billions of health care dollars, millions of work days, and hundreds of thousands of lives are lost each year to extraintestinal infections due to E. coli. New treatments and prevention measures will be needed for improved outcomes and a diminished disease burden.
                Bookmark

                Author and article information

                Journal
                Open Forum Infect Dis
                Open Forum Infect Dis
                ofid
                Open Forum Infectious Diseases
                Oxford University Press (US )
                2328-8957
                November 2019
                09 October 2019
                09 October 2019
                : 6
                : 11
                : ofz431
                Affiliations
                [1 ] School of Population and Public Health, The University of British Columbia , Vancouver, BC, Canada
                [2 ] Department of Laboratory Medicine & Pathology, University of Alberta , Edmonton, AB, Canada
                [3 ] Public Health Laboratory (ProvLab) , Edmonton, AB, Canada
                [4 ] Department of Microbiology and Immunology, The University of British Columbia , Vancouver, BC, Canada
                [5 ] Center for Food-borne, Environmental and Zoonotic Infectious Disease, Public Health Agency of Canada , Guelph, ON, Canada
                [6 ] National Microbiology Laboratory, Public Health Agency of Canada , Saint-Hyacinthe, QC, Canada
                [7 ] Department of Medical Microbiology, University of Manitoba , Winnipeg, MB, Canada
                [8 ] National Microbiology Laboratory, Public Health Agency of Canada , Winnipeg, MB, Canada
                [9 ] Department of Population Medicine, Ontario Veterinary College, University of Guelph , Guelph, ON, Canada
                [10 ] Dalla Lana School of Public Health, University of Toronto , Toronto, ON, Canada
                [11 ] Department of Pathobiology, Ontario Veterinary College, University of Guelph , Guelph, ON, Canada
                [12 ] British Columbia Centre for Disease Control , Vancouver, BC, Canada
                Author notes
                Present affiliation: Department of Medicine, The University of British Columbia, Vancouver, BC, Canada
                Present affiliation: Canada’s Michael Smith Genome Sciences Centre, Vancouver, BC, Canada
                Present affiliation: Gillings School of Global Public Health, The University of North Carolina, Chapel Hill, NC, USA
                Correspondence: A. R. Manges, MPH, PhD, UBC, School of Population and Public Health, 2206 East Mall, Vancouver, BC V6T 1Z3 Canada ( amee.manges@ 123456ubc.ca ).
                Article
                ofz431
                10.1093/ofid/ofz431
                6824535
                31696141
                0a6b0576-54da-4317-a8eb-ba92e467d9e0
                © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence ( http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 06 August 2019
                : 04 October 2019
                : 19 September 2019
                : 01 November 2019
                Page count
                Pages: 11
                Funding
                Funded by: Canadian Institutes of Health Research Canada Graduate Scholarship Master’s Award
                Award ID: 6556
                Funded by: Canadian Institutes of Health Research Institute of Infection and Immunity
                Award ID: MOP-114879
                Categories
                Major Article

                antimicrobial resistance,extraintestinal pathogenic escherichia coli,food safety,molecular epidemiology,urinary tract infections

                Comments

                Comment on this article